APA (7th ed.) Citation

Valenti, M., Ibba, L., Cascio Ingurgio, R., Malagoli, P., Carugno, A., Campoli, M., . . . Narcisi, A. (2024). A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis). Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology, 14(11), 2987. https://doi.org/10.1007/s13555-024-01270-5

Chicago Style (17th ed.) Citation

Valenti, Mario, et al. "A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis)." Dermatology and Therapy: Research, Treatment and Aesthetic Interventions in Dermatology 14, no. 11 (2024): 2987. https://doi.org/10.1007/s13555-024-01270-5.

MLA (9th ed.) Citation

Valenti, Mario, et al. "A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis)." Dermatology and Therapy: Research, Treatment and Aesthetic Interventions in Dermatology, vol. 14, no. 11, 2024, p. 2987, https://doi.org/10.1007/s13555-024-01270-5.